The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

Many of our scientists are focussed on developing treatments that can slow down or stop the diseases that cause dementia. This work is vital, as currently there are no drugs available on the NHS that ...

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

The NAPA Reauthorization Act extends the National Alzheimer's Plan through 2035, prioritizing healthy aging, risk reduction, ...

Experts say there are ways to reduce our risk of dementia, including diet and exercise, protecting against hearing loss, and maintaining social connections.

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

The approved drugs for Alzheimer’s disease do not address the underlying cause of the disease, but instead treat only the symptoms. However, there is a vast array of experimental treatments that are ...

While Alzheimer’s disease (AD) has no cure, five prescription medicines have been approved by the U.S. Food and Drug Administration (FDA) to treat disease symptoms that impact thinking and memory.